ArticleJournal of medical case reports2025
Clinical analysis of non-ketotic hyperglycemia with reversible cortical blindness: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundNon-ketotic hyperglycemia is a clinical syndrome caused by poor blood glucose control, which can lead to unilateral chorea, seizures, headaches, and other neurological deficit symptoms. Due to the lack of specificity of clinical symptoms and unclear pathogenesis, many patients are misdiagnosed and may delay treatment. CASE PRESENTATION: Two male patients of Han nationality in China, one 61 years old and the other 33 years old, were admitted to our hospital with persistent hemianopia and headache, both with a background of type 2 diabetes mellitus and poor glycemic control on admission. They also had abnormal signals on magnetic resonance imaging of the head, manifested as focal subcortical hypointensity and cerebral gyrus hyperintensity. Through comprehensive evaluation of clinical features, imaging changes, and treatment effect, the diagnosis of non-ketotic hyperglycemia was considered to be relatively clear. After active diagnosis and treatment, reasonable control of blood glucose, clinical symptoms, and abnormal imaging changes disappeared completely. No evidence of recurrence was found in patients with follow-up for half a year.
conclusionClinicians should improve the necessity of non-ketotic hyperglycemia screening for patients with sudden headache, visual field defect, epilepsy, and hemichorea. This case report emphasizes the clinical diagnosis and treatment ideas and measures of non-ketotic hyperglycemia to increase the sensitivity of clinical diagnosis and the clinical detection rate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.